Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PCDHA9 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PIAS2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | LRRC8B | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | SLC12A4 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | MAU2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | CDKN2C | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | H3F3A | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | NEUROD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | FAM171A2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | DDX25 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |